Franklin Resources’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $671K | Buy |
72,780
+6,662
| +10% | +$61.4K | ﹤0.01% | 2179 |
|
2025
Q1 | $567K | Buy |
66,118
+7,561
| +13% | +$64.9K | ﹤0.01% | 2203 |
|
2024
Q4 | $629K | Hold |
58,557
| – | – | ﹤0.01% | 2179 |
|
2024
Q3 | $317K | Buy |
58,557
+3,674
| +7% | +$19.9K | ﹤0.01% | 2461 |
|
2024
Q2 | $232K | Buy |
54,883
+36,711
| +202% | +$155K | ﹤0.01% | 2520 |
|
2024
Q1 | $92.5K | Sell |
18,172
-7,337
| -29% | -$37.3K | ﹤0.01% | 2710 |
|
2023
Q4 | $237K | Buy |
25,509
+11,579
| +83% | +$108K | ﹤0.01% | 2276 |
|
2023
Q3 | $91.2K | Sell |
13,930
-20,771
| -60% | -$136K | ﹤0.01% | 2458 |
|
2023
Q2 | $282K | Buy |
+34,701
| New | +$282K | ﹤0.01% | 2229 |
|